68D-21125-24125
3 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 152 / PA
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Moderna
-
2021-01-05
Registered in v-safe
- 2021-01-05
- 2021-01-06
- 2021-01-13
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
- 2021-01-28
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-26
- 2021-03-03
- 2021-03-10
- 2021-04-30
- 2021-07-30
-
2021-12-05
Dose 3 — Moderna
- 2022-01-29
-
2022-03-06
Survey response — 3 months, dose 3MedDRA: Respiratory tract infection, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Current respiratory infection. Tested negative for COVID with home testing kit.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-12-05 | Moderna | No |
Free text
Release 11 — 3 months, dose 3
Symptoms: Current respiratory infection. Tested negative for COVID with home testing kit.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract infection | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release